Patents Assigned to EBI ANTI SEPSIS B.V.
  • METHODS OF TREATMENT FOR MODIFYING HEMODYNAMICS
    Publication number: 20220370543
    Abstract: This disclosure provides method of treatment comprising administering an AQGV peptide, or a functional analog thereof, to a human subject, the human subject optionally having impaired kidney function, wherein the treatment of administering an AQGV peptide comprises maintaining or improving hemodynamic stability in the human subject, such as a human subject suffering or considered suffering from Clarkson's disease (CLS).
    Type: Application
    Filed: September 30, 2020
    Publication date: November 24, 2022
    Applicants: EBI ANTI SEPSIS B.V., EBI ANTI SEPSIS B.V.
    Inventors: Roelof Peter Pickkers, Gert Wensvoort